0001062993-21-012053.txt : 20211202 0001062993-21-012053.hdr.sgml : 20211202 20211202184930 ACCESSION NUMBER: 0001062993-21-012053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211130 FILED AS OF DATE: 20211202 DATE AS OF CHANGE: 20211202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HURWITZ EDWARD CENTRAL INDEX KEY: 0001211840 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36370 FILM NUMBER: 211468212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED GENETIC TECHNOLOGIES CORP CENTRAL INDEX KEY: 0001273636 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 593553710 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 14193 NW 119TH TERRACE STREET 2: SUITE #10 CITY: ALACHUA STATE: FL ZIP: 32615 BUSINESS PHONE: 386-462-2204 MAIL ADDRESS: STREET 1: 14193 NW 119TH TERRACE STREET 2: SUITE #10 CITY: ALACHUA STATE: FL ZIP: 32615 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2021-11-30 0001273636 APPLIED GENETIC TECHNOLOGIES CORP AGTC 0001211840 HURWITZ EDWARD C/O APPLIED GENETIC TECHNOLOGIES CORP. 14193 NW 119TH TERRACE, SUITE #10 ALACHUA FL 32615 1 0 0 0 Stock Option (right to buy) 2.17 2021-11-30 4 A 0 14000 0 A 2031-11-30 Common Stock 14000 14000 D The option becomes exercisable in equal monthly installments over one year from the date of grant. /s/ Stacie Aarestad, Attorney-in-fact 2021-12-02